Clinical Trial Update: Clinical Trial Studying the Effects of Spironolactone on Heart and Skeletal Muscle Function in Chronic Alcoholics [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating spironolactone's effects on heart and skeletal muscle function in chronic alcoholics has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Alcoholic Cardiomyopathy

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: University of Aarhus | Conditions: Cardiomyopathy, Alcoholic, Alcoholism | Phase 4 | Status: SUSPENDED